Bristol Myers Squibb

Some of the key events about Bristol Myers Squibb

• 1887

  The company was founded as a drug manufacturing firm in Brooklyn, New York
• 1943

  Developed one of the world's first mass-produced penicillin for commercial use
• 1954

  Introduced the first oral penicillin, Penicillin V
• 1967

  Launched the first synthetic antibiotic, Cephalexin
• 1989

  Introduced Capoten, the first angiotensin-converting enzyme (ACE) inhibitor for treating hypertension
• 1989

  Faced allegations of fraudulently marketing the anti-anxiety drug Buspar
• 1991

  Developed Taxol, a groundbreaking cancer treatment derived from Pacific yew tree bark
• 1994

  Accused of inflating prices of cancer and AIDS drugs
• 2001

  Paid $670 million to settle lawsuits over contaminated blood products
• 2002

  Launched Plavix, a widely used antiplatelet medication
• 2003

  Charged with conspiracy to commit securities fraud
• 2007

  Pleaded guilty to making false statements to the FDA about Plavix
• 2010

  Paid $158 million to settle allegations of Medicaid fraud in Texas
• 2011

  Received FDA approval for Yervoy, the first immunotherapy for advanced melanoma
• 2012

  Agreed to pay $80 million for bribing doctors in China
• 2014

  Introduced Opdivo, an innovative immunotherapy drug for cancer treatment
• 2015

  Faced criticism for dramatically increasing the price of a cancer drug
• 2016

  Accused of withholding data about a failed drug trial
• 2019

  Acquired Celgene Corporation, significantly expanding its oncology and hematology portfolio
• 2019

  Paid $75 million to resolve Foreign Corrupt Practices Act charges

Disclaimer: This material is written based on information taken from open sources, including Wikipedia, news media, podcasts, and other public sources.